Ozempic maker Novo rises after first stock split in a decade

(Bloomberg) — Novo Nordisk A/S shares rose slightly on Wednesday in the first trading session following a two-for-one split aimed at increasing the liquidity of the Danish drugmaker’s soaring stock.

Most Read from Bloomberg

Novo gained 0.4% to about 684 Danish kroner after the separation, which the maker of weight-loss drugs Ozempic and Wegovy has said will bring price levels for its Copenhagen-listed shares and American Depositary Receipts “in line with market practice.”

Novo shares…

Read More